|
Autumn 2003
• Volume XII, Number 4
The Latest in...
|
ALTERNATIVES TO ANIMAL EXPERIMENTATION
|
Keeping
the “Life” in Life Sciences
The University of Utrecht in the Netherlands has created a graduate
program for the replacement of animal experimentation in its Institute
of Life Sciences and Chemistry. Set up in cooperation with the Dutch
Anti-Vivisection Group and the National Center for Alternatives,
the program will teach students how to create and validate alternative
research protocols and how to perfect the use of tissue and synthetic
models and computer simulators which are already in use. New techniques
that are developed are expected to influence other universities,
research institutions, chemical companies, and the pharmaceutical
industry. The four-year program takes a nonanimal approach to biology,
biochemistry, physiology, pathology, pharmacology, embryology, and
other fields of study.
Successful In-Vitro Embryotoxicity Screen
A test that may save countless animals and research dollars by flagging
potentially embryotoxic chemicals is now available in the United
States. In 2002, scientists in Europe confirmed the accuracy of
the Rodent Embryonic Stem Cell Test (EST), an in-vitro
test used in place of experiments that involve force-feeding test
chemicals to pregnant animals to determine potential harm to their
embryos. It classifies substances from non-embryotoxic to highly
embryotoxic so scientists can assess whether more specific immunological,
cellular, or molecular tests are warranted.
EST will enable companies to spot dangers early, cease drug or
chemical development when necessary, and avoid animal tests—mandatory,
yet inadequate, predictors of human risk. The test uses immortal
cell lines that are kept frozen until needed; therefore, once cell
lines are established, no further animals are killed in the procedure.
EST is now being conducted at the Institute for In Vitro Sciences,
Inc., in Gaithersburg, Md., and is available to other companies.
Genschow E, Spielmann H, Scholz G, et al. The
ECVAM international validation study on in vitro embryotoxicity
tests: Results of the definitive phase and evaluation of prediction
models. ATLA 2002;30:151-76.
New Software Streamlines Drug Research
Scientists at India’s Central Drug Research Institute have
adopted Drug Discovery Assistant software (“DD Assist”)
for testing the toxicity of various chemicals. Previously, new drugs
were developed using animal tests, which drained resources through
decades of hit-or-miss trials. DD Assist will reduce the numbers
of animals used by 90 percent and bring safer drugs to market much
more rapidly. Although high subscription rates made it difficult
for much of the world to acquire the software in the past, Invenio
Biosolutions of New Delhi has now created a more affordable version
that will allow India’s drug industry to compete with developed
nations.
Academic Update
After a two-year campaign, University of Illinois at Urbana-Champaign
undergraduates won the right to use alternatives to animal dissection.
Proponents of the change cited more than 60 peer-reviewed studies
demonstrating the efficacy of dissection alternatives and pointed
to the free exercise of religion clause of the First Amendment,
which, in their view, protects students from being forced to harm
animals while receiving a public university education.
Dairy-Based
Formula Linked to High Blood Pressure
A study in the American Journal of Clinical Nutrition found
that infants fed milk-based baby formula grew up to have higher
blood pressure than babies who were breastfed. Researchers at the
University of Bristol followed up with 951 babies born between 1972
and 1974 who were either given a milk-based baby formula or were
breastfed.
Those babies who consumed the most dried milk had a 6.1 mm Hg greater
systolic blood pressure and a 2.3 mm Hg greater diastolic blood
pressure than those who consumed the least.
It is unclear whether milk’s high sodium, fat, or calorie
content are to blame, or if mothers who breastfeed tend to encourage
healthier eating habits in their children. It is certain, however,
that breastfeeding provides many long-term health benefits.
Martin RM, McCarthy A, Smith GD, Davies DP,
Ben-Shlomo Y. Infant nutrition and blood pressure in early adulthood:
the Barry Caerphilly Growth study. Am J Clin Nutr 2003;77:1489-97.
The Fat You Can’t See Can Hurt You, Too
Rolls of body fat are naturally a concern of doctors, but new research
from Johns Hopkins University shows that visceral fat, which surrounds
vital organs and is not visibly obvious from the outside, increases
the risk for heart disease and diabetes, too.
Researchers at Johns Hopkins asked 84 healthy adults aged 55 to
75 to keep a food diary for three days and then undergo an abdominal
MRI scan to look for visceral fat. They found that diets high in
saturated fats—found in lard, butter, and meats—were
most likely to encourage visceral fat formation. Those with high
waist-to-hip ratio measurements were also likely to have too much
fat padding their organs. This type of underlying fat is a high
risk factor for heart attack.
American College
of Cardiology 52nd Annual Scientific Session
Atkins Diet: No Miracle, According to New Studies
A study in the New England Journal of Medicine found that,
although the Atkins regimen caused early weight loss in dieters,
they soon regained the pounds they shed.
The yearlong study involved 63 obese men and women who were randomly
assigned to either a low-carbohydrate, high-protein, high-fat (Atkins)
diet or to a conventional, low-calorie diet. The Atkins diet group
lost more weight during the first six months, but, at the end of
one year, differences among the groups were not significant. Adherence
was poor in both groups. The study provides further evidence that
the Atkins regimen, which is severely low in carbs, is simply a
low-calorie diet out of sync with healthy eating patterns and does
not sustain long-term weight regulation.
Foster GD, Wyatt HR, Hill JO, et al. A randomized
trial of a low-carbohydrate diet for obesity. N Engl J Med 2003;348:2082-90.
Obesity Cuts Life Short
It’s no secret that obesity fuels a great many illnesses,
but now researchers have estimated how many years of life may be
lost when weight problems are left untreated. Data from previous
studies on individuals aged 18 to 85 were analyzed, and body mass
index (a measure of body weight adjusted for height) was calculated.
Young black men with a BMI above 45 faired worst, reducing their
lifespan by 20 years. Young black women with similar obesity levels
reduce their lifespan by 5 years. Young white men and young white
women with a BMI greater than 45 lost 13 and 8 years of life, respectively.
Optimal BMI is 23 to 25 for white people and 23 to 30 for black
people.
Fontaine KR, Redden DT, Wang C, Westfall AO,
Allison DB. Years of life lost due to obesity. JAMA 2003;289:187-93.
Research
at VA Hospitals Endangers Lives
Veterans’ hospitals across the United States are under criminal
investigation for violations of federal safety rules, including
some that may have contributed to the deaths of patients.
The Department of Veterans Affairs identified cases in which researchers
falsified data and failed to explain the risks of experimental procedures
to patients. An overdose of prescription drugs is believed to have
caused the death of one participant in Detroit. A blood pressure
study in Fargo, North Dakota, was linked to the death of one patient,
with more than 20 other patients suffering severe adverse reactions
to the drugs. Injuries in Albany, Pittsburgh, Providence, Portland,
and California are also under investigation.
|
HORMONE REPLACEMENT THERAPY
|
Hormone Therapy Linked to Dementia
The major U.S. government study on long-term estrogen-progestin
use, which was partially terminated last year because of increased
risks of breast cancer, heart attack, and stroke, has also found
an increased risk for dementia. When taken for more than four years,
the hormone appears to have a detrimental effect, impairing cognitive
function in women age 65 or older. It did not prevent mild cognitive
impairment as once thought.
This offshoot examination, the Women’s Healthy Initiative
Memory Study, was conducted by Wake Forest University and involved
4,532 women, half of whom used Prempro estrogen-progestin pills
and half of whom received a placebo. Since the original study began
uncovering serious healthy risks, sales of Premarin and Prempro
have dropped significantly.
Rapp SR, Espeland MA, Shumaker SA, et al. Effect
of estrogen plus progestin on global cognitive function in postmenopausal
women: the women’s health initiative memory study: a randomized
controlled trial. JAMA 2003;289:2663-72.
Media
Center | Health | Research
| About PCRM | Catalog
| Join Us | Search
| Site Index | Home
The site does
not provide medical or legal advice. This Web site is for information purposes
only.
Full Disclaimer | Privacy Policy
|